Edwards Lifesciences CorpNYSE:EW
Symbol Lookup
Refresh
Recent News»
1 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Waters Corp WAT | 8.6B | 17.9x | +14.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ResMed Inc RMD | 6.7B | 22.3x | +32.14% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hologic Inc HOLX | 5.5B | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Varian Medical Systems Inc VAR | 7.5B | 17.6x | +15.14% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Illumina Inc ILMN | 8.8B | 94.1x | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. The Company also provides hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into three main areas: Surgical Heart Valve Therapy, which combines surgical heart valves and Cardiac Surgery Systems; Transcatheter Heart Valves; and Critical Care, which includes Vascular. In October 2012, it acquired BMEYE B.V.
| Headquarters | One Edwards Way IRVINE, CA, United States 92614 |
|---|---|
| Phone | 949-250-2500 |
| Fax | 302-655-5049 |
EXECUTIVE OFFICERS
| Chairman of the Board, Chief Executive Officer | Michael Mussallem |
|---|---|
| Chief Financial Officer, Corporate Vice President | Thomas Abate |
| Corporate Vice President, General Counsel | Aimee Weisner |
| Corporate Vice President - Human Resources | Christine McCauley |
| Corporate Vice President - Heart Valve Therapy | Donald Bobo |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $7.8B | Beta | 0.48 |
|---|---|---|---|
| Revenue (TTM) | $1.9B | EPS | $3.17 |
| Shares Out. | 113.0M | Book Value | $12.94 |
| Dividend Yield | 0.00% | P/E | 21.7x |
| Annual Dividend Rate | $0.00 | Price/Sales (TTM) | 4.0 |
| Ex-Div Date | 1/1/01 | P/Cash Flow (TTM) | 18.0x |
| Pay Date | 1/1/01 | Operating Margin | 25.78% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
